GM and pharma crop vaccines: Dr Mae Wan Ho

[Guest guest]

Dangers of HPV Vaccine Production in Plants, Microbes, and ###############################################Viruses######Widespread releases of hazardous transgenes and vaccines have the potential to create viruses more deadly than the ones the vaccines protect against Prof. Joe Cummins and Dr. Mae-Wan HoHuman papilloma virus (HPV) vaccines are already commercialised and promoted worldwide in a bid to protect young girls and women from cervical cancer [1, 2] (Recombinant Cervical Cancer Vaccines, SiS 29; The HPV Vaccine Controversy, SiS 41), while there is still major uncertainty over their efficacy and safety, especially in the long term. One obstacle to the adoption of the vaccines by developing countries is that the two available are very costly. There appears to have been a rush

to create cheap oral HPV vaccines in transgenic plants, microbes and viruses that do not require refrigeration and can be distributed relatively inexpensively, but would involve widespread releases of hazardous transgenes and products into the open environment. Some of these are near commercialization, and regulators must be warned against the approval of such production methods unless and until strict containment and safeguards are put in place. HPV vaccines in crop plantsThe main concern over the vaccines produced in crop plants is that transgenes from tests sites or production farms can readily spread by pollen or by mechanical dispersal of seeds. Debris from transgenic crops can also spread transgenes and vaccine proteins through contaminating surface and groundwater. Debris in the form of dust in the air can impact on the respiratory mucosa directly, with

the potential of triggering acute and delayed immune reactions in humans and animals exposed. HPV vaccines have already been associated with various adverse acute immune reactions some of which resulted in death [2]. People subject to persistent exposure to the crop vaccine are likely to develop oral tolerance rendering them susceptible to virus infection [3] (Pharm Crops for Vaccines and Therapeutic Antibodies, SiS 24)..There have been reports since 2006 that HPV virus and L1 proteins were produced in plants including transgenic potato, tobacco and a wild tobacco N. benthamiana [4]. HPV L1 virus-like particles were expressed in transgenic potatoes and these particles were found to immunize animals fed the potatoes. The gene for the particle protein L1 had been optimized for activity in potato by codon alterations. The full length message had a

C-terminal signal sequence for nuclear localization of the protein and production of the L1 protein is enhanced by removal of the signal sequence for nuclear localization. The oral immunization using transgenic potato had to be enhanced by ingesting LI protein produced from insect cell (baculovirus) cultures.[5]. Comparing the production of HPV19 L1 in cytoplasm or chloroplast of Nicotiana benthamiana showed that the vaccine was produced most effectively in the chloroplasts. Adjustments in codon preferences showed that the human codon preference was most effective in enhancing production of the vaccine. The optimally engineered gene configuration produced up to 11 percent of the plant’s soluble protein as L1 vaccine protein [6]. The HPV 16 L1 protein produced in N. benthamiana proved very immunogenic following injection in mice [7]. Another N. benthamiana

chloroplast transformation produced up to 1.5 percent total leaf protein as HPV L1 whose half life in the leaf was at least 8 hours [8].Read the rest of this article herehttp://www.i-sis.org.uk/HPV_Vaccine_Production_Plants.phpWWII – a war that cost the lives of more than 60 million people – was planned and financed by the world’s largest chemical/ pharmaceutical cartel. At that time Germany’s I.G. Farben consisted of Bayer, BASF, Hoechst and others.- Dr Mathius Rath

Add more friends to your messenger and enjoy! Invite them now.